T. Rowe Price Associates
ALVO icon

T. Rowe Price Associates’s Alvotech ALVO Stock Holding History

T. Rowe Price Associates’s Portfolio ALVO Stock Details ALVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.23M Buy
1,418,392
+21,285
+2% +$76.1K ﹤0.01% 1543
2026
Q1 		$4.79M Sell
1,397,107
-37,046
-3% -$163K ﹤0.01% 1436
2025
Q4 		$7.36M Sell
1,434,153
-19,557
-1% -$124K ﹤0.01% 1299
2025
Q3 		$11.9M Buy
1,453,710
+63,799
+5% +$544K ﹤0.01% 1183
2025
Q2 		$12.7M Sell
1,389,911
-11,510
-0.8% -$108K ﹤0.01% 1068
2025
Q1 		$13.6M Buy
+1,401,421
New +$17M ﹤0.01% 1047

Other funds holding ALVO

BCL
Bracebridge Capital LLC Boston, Massachusetts $5.53B AUM 25.79% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates's ALVO Position: Q2 2026 in Review

T. Rowe Price Associates increased its Alvotech (ALVO) stake by 1.5% in Q2 2026, buying an estimated $76.1K and bringing the position to 1,418,392 shares worth $5.23M. The position accounts for ﹤0.01% of the portfolio, ranked #1543.

T. Rowe Price Associates first reported a position in ALVO in Q1 2025 and has held it in 6 quarters since. The position peaked at $13.6M in Q1 2025. 65 funds tracked by Wall St. Rank hold ALVO as of Q2 2026.

  • T. Rowe Price Associates held 1,418,392 shares of Alvotech worth $5.23M as of Q2 2026.
  • T. Rowe Price Associates bought 21,285 Alvotech shares in Q2 2026, an estimated $76.1K.
  • Alvotech made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #1543 holding.
  • T. Rowe Price Associates first reported a position in Alvotech in Q1 2025 and has held it in 6 quarters since.
  • T. Rowe Price Associates's Alvotech position peaked at $13.6M in Q1 2025.
  • 65 funds tracked by Wall St. Rank held Alvotech as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.